PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Flexi Communications

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kyrgyz Pharmaceutical Company Pharmaco Group Enters the Central Asian Markets - Kyrgyz pharmaceutical company Pharmaco Group enters the Central Asian markets The strategic goal of Pharmaco Group is to boost its export potential in Central Asia (Uzbekistan, Tajikistan and Afghanistan). By the end of 2009 the facility will launch
Kyrgyz Pharmaceutical Company Pharmaco Group Enters the Central Asian Markets

 

NewswireToday - /newswire/ - Bishkek, Kazakhstan, 2009/05/02 - Kyrgyz pharmaceutical company Pharmaco Group enters the Central Asian markets The strategic goal of Pharmaco Group is to boost its export potential in Central Asia (Uzbekistan, Tajikistan and Afghanistan). By the end of 2009 the facility will launch.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

At the international exhibition "Healthcare – TIHE 2009" that took place in Tashkent provisional agreements were made between the domestic manufacturer Pharmaco Group, and regional distributors, the company informs.

"The medical forum enabled the company to show itself to be the new Central Asian manufacturer of high quality medications. The level and size of the exhibition – which resulted in hundreds of contracts being signed each day - allowed us to reach all of our set goals. We carried out the analysis of Uzbekistan’s pharmaceutical market, met the leading medical professionals and representatives of distributing companies. Presently we are to choose an exclusive partner to represent us in Uzbekistan, register and distribute Pharmaco Group products in the republic", says Alexander Karpov, Pharmaco Group General Director, as quoted by the company press office.

According to A. Karpov, “Pharmaco Group products generated considerable interest among distributors and doctors due to their good value for money; particular attention was drawn to the antibiotic group manufactured at the Bishkek facility, particularly cefazolin, which currently is a sought-for medication in the Uzbek pharmaceutical market”.

“Considering the fact that Uzbekistan is the most densely populated country in Central Asia, the pharmaceutical market of the republic has very promising prospects for Pharmaco Group. On the other hand, as it turned out, the neighboring state was in need of generic medications. We have already begun working on forming the product mix proposal,” notes the head of the company, as quoted by the press office.

Pharmaco Group is a pharmaceutical plant located in Bishkek, the Kyrgyz capital. Its annual output equals 500 million pills, 100 million capsules and 12 million vials of antibiotic powders. These medications are used in gastroenterology, dermatology, gynecology, urology, rheumatology, cardiology and pediatrics.

The strategic goal of Pharmaco Group is to boost its export potential in Central Asia (Uzbekistan, Tajikistan and Afghanistan). By the end of 2009 the facility will launch production of six antituberculous drugs - capreomicin, pyrazinamide, cycloserine, paraaminosalicylic acid, protionamide and ofloxacin. In the nearest future Pharmaco Group is planning to introduce antidiabetic medications such as gliclazide and metformin to its product portfolio.

"Healthcare – TIHE 2009" is the annual Central Asian exhibition project. In 2009 it was held for the fourteenth time and included four specialized medical exhibitions devoted to healthcare, pharmaceutical industry, aesthetic medicine and dentistry. Companies from Russia, China, USA, Great Britain, Switzerland, Turkey South Korea and the Central Asian countries are among the participants and attendees of the event.

MGN Analysis
Pharmaco Group, a pharmaceutical manufacture, which began operating in 2008 and is headquartered in Bishkek Kyrgyzstan, announced that it is expanding to other Central Asia markets. The company, which produces various generic and specialty drugs in pill, capsule and vial form, has been aggressively growing in the Kyrgyz market and is now seeking to expand in neighboring markets. The pharmaceutical market in Kyrgyzstan and neighbor countries is estimated in excess of $1.0 bln UDS. MGN anticipated Pharmaco’s ability to grow to external markets as the company is known to produce high quality pharmaceutical products in Kyrgyzstan. MGN believes that this is just the first in a series of success stories to come from this company. We anticipate that Pharmaco Group will boldly compete with other pharmacy companies in Central Asia and is a highlight in the Kyrgyz business community.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Flexi Communications

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kyrgyz Pharmaceutical Company Pharmaco Group Enters the Central Asian Markets

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Elmira Mamytbekova - FlexiCommunications.com 
+996 312 62 25 84 Sophya.balakina[.]flexicommunications.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Flexi Communications securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Flexi Communications / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Intrinsic Executive Search Ltd

Visit  NAKIVO, Inc.





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)